Top Stories
Top Stories
Wires

REGENERON-INDEPENDENT DATA SAFETY MONITORING BOARD DECIDED TO STOP PALM EBOLA CLINICAL TRIAL AFTER REVIEWING INTERIM MORTALITY DATA FROM 499 PATIENTS